Suppr超能文献

不同呼吸支持方式预防 COPD 患者行纤维支气管镜检查时缺氧的效果:一项三臂、随机对照试验。

Efficacy of different respiratory supports to prevent hypoxia during flexible bronchoscopy in patients of COPD: a triple-arm, randomised controlled trial.

机构信息

Pulmonary & Critical Care Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.

Pulmonary & Critical Care Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

出版信息

BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2022-001524.

Abstract

BACKGROUND

Patients with chronic-obstructive-pulmonary-disease (COPD) undergo bronchoscopy for various reasons, and are at relatively higher risk of complications. This study evaluated the efficacy of non-invasive ventilation (NIV) and high-flow-oxygen-therapy (HFOT) compared with conventional-oxygen-therapy (COT) in patients with COPD undergoing bronchoscopy, to prevent hypoxia.

METHODS

It was a triple-arm, open-label, randomised controlled trial. Ninety patients with COPD were randomly assigned into three intervention arms in 1:1:1 ratio. The incidence of hypoxia, lowest recorded oxygen saturation measured by plethysmography (SpO), ECG, patient vitals and comfort levels were assessed.

RESULTS

Mean age of the study population was 61.71±7.5 years. Out of 90 cases enrolled, 51, 34 and 5 were moderate, severe and very-severe COPD, respectively, as per GOLD (Global Initiative for Chronic Obstructive Lung Disease) classification. Rest of the baseline characteristics were similar. SpO during flexible bronchoscopy (FB) was lowest in COT group (COT: 87.03±5.7% vs HFOT: 95.57±5.0% vs NIV: 97.40±1.6%, p<0.001). Secondary objectives were similar except respiratory-rate (breaths-per-minute) which was highest in COT group (COT: 20.23±3.1 vs HFOT: 18.57±4.1 vs NIV: 16.80±1.9, p<0.001). Whereas post FB partial of oxygen in arterial blood was highest in NIV group (NIV: 84.27±21.6 mm Hg vs HFOT: 69.03±13.6 mm Hg vs COT: 69.30±11.9 mm Hg, p<0.001). Post FB partial pressure of carbon dioxide in arterial blood was similar in the three arms. Operator's ease-of-performing-procedure was least in the NIV group as assessed with Visual Analogue Scale (p<0.01). A higher number of NIV group participants reported nasal pain as compared with the other two arms (p<0.01).

CONCLUSION

NIV and HFOT are superior to COT in preventing hypoxia during bronchoscopy, but NIV is associated with poor patient-tolerance and inferior operator's ease of doing procedure.

TRIAL REGISTRATION NUMBER

CTRI/2021/03/032190.

摘要

背景

慢性阻塞性肺疾病(COPD)患者因各种原因接受支气管镜检查,并发并发症的风险相对较高。本研究评估了无创通气(NIV)和高流量氧疗(HFOT)与常规氧疗(COT)相比,在预防缺氧方面对 COPD 患者支气管镜检查的疗效。

方法

这是一项三臂、开放标签、随机对照试验。90 例 COPD 患者按 1:1:1 的比例随机分为三组。评估了缺氧发生率、脉搏血氧仪(SpO)测量的最低记录血氧饱和度、心电图、患者生命体征和舒适度。

结果

研究人群的平均年龄为 61.71±7.5 岁。90 例入组患者中,51 例、34 例和 5 例分别为中度、重度和极重度 COPD,按 GOLD(全球慢性阻塞性肺疾病倡议)分类。其余基线特征相似。COT 组在纤维支气管镜(FB)期间的 SpO 最低(COT:87.03±5.7%vsHFOT:95.57±5.0%vsNIV:97.40±1.6%,p<0.001)。次要目标相似,除呼吸频率(每分钟呼吸次数)外,COT 组最高(COT:20.23±3.1vsHFOT:18.57±4.1vsNIV:16.80±1.9,p<0.001)。而 NIV 组动脉血中氧的部分压力最高(NIV:84.27±21.6mm Hg vsHFOT:69.03±13.6mm Hg vsCOT:69.30±11.9mm Hg,p<0.001)。三组动脉血中二氧化碳分压相似。NIV 组的操作者进行操作的舒适度最低(通过视觉模拟量表评估,p<0.01)。与其他两组相比,NIV 组有更多的参与者报告了鼻痛(p<0.01)。

结论

与 COT 相比,NIV 和 HFOT 可更好地预防支气管镜检查期间的缺氧,但 NIV 与较差的患者耐受性和较差的操作者操作舒适度相关。

试验注册号

CTRI/2021/03/032190。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cb3/10632894/f7477c7b2adf/bmjresp-2022-001524f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验